Treatment of chronic lymphocytic leukaemia, where are we heading?. Hematological Oncology 33 :10.1002/hon.v33.S1, 46-49 /Susan M.O'Brien. (2015) VIII. Treatment of chronic lymphocytic leukaemia, where are we heading?. Hematological Oncology 33 :10.1002/hon.v33.S1, 46-49 /...
In 1982 the IGCI CLL cooperative group decided to investigate the usefulness of treating, at diagnosis B-cell chronic lymphocytic leukemia (CLL) in early and stable phase of the disease. From January 1982 to December 1986, 148 patients were randomized either to receive immediate treatment with chl...
Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells Irina,Idler,Krzysztof,... - 《British Journal of Haematology》 被引量: 99发表: 2010年 Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic ...
: Staging of chronic lymphocytic leukemia. Blood 1982; 59: 1191–1196. Montserrat E, Sanchez-Bisono J, Vinolas N et al. : Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. Br J Haematol 1986; 62: 567–575 CrossRef Molica S, Alberti A: ...
Brentjens R, Yeh R, Bernal Y, Riviere I, Sadelain M. Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial. Mol Ther. 2010;18:666–8. ...
Ibrutinib: A major breakthrough in the treatment of CLL and other lymphoproliferative disorders D Bron 被引量: 0发表: 2013年 Ibrutinib: A Review of Its Use in Patients with Mantle Cell Lymphoma or Chronic Lymphocytic Leukaemia Ibrutinib (Imbruvica庐) is a first-in-class, potent, orally ...
Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine Recently there has been an increased awareness of a possible link between the use of purine nucleoside analogues and myelodysplasia. We report the case of ... Hennessy, B. J,S Ryley,A Kasprzyk,... - 《Hematology...
Moreover, various studies affirmed the CD20-CAR T cell safety and efficacy in R/R Non-Hodgkin’s lymphoma (NHL), follicular- and mantle cell lymphomas [78,79]. Additionally, treatment of chronic lymphocytic leukemia (CLL) as another common hematological malignancy was investigated by using the ...
Acute lymphoblastic leukemic (ALL) has served as the model for the cure of neoplasia by chemotherapy for several decades, but even now fewer than half of adult patients achieve long disease-free survival (DFS). Steady improvements in the cure rate for adults have been achieved through more accu...
Treatment of B‐cell chronic lymphocytic leukaemia: current status and future perspectives In the last two decades, important advances have been made in the biology, natural history, and prognosis of B‐cell chronic lymphocytic leukaemia (CLL). I... E.,MONTSERRAT,F.,... - 《Journal of Intern...